Madrigal Pharmaceuticals, Inc. (MDGL)
CIK 1157601 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Madrigal Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 144 | 0001950047-26-009360 |
| Sep 11, 2026 | 4 | 0001628280-26-061581 |
| Sep 9, 2026 | 144 | 0001628280-26-061190 |
| Aug 20, 2026 | 4 | 0001628280-26-058256 |
| Aug 20, 2026 | 144 | 0001628280-26-058254 |
| Aug 18, 2026 | 3 | 0001628280-26-057747 |
| Aug 18, 2026 | 4 | 0001628280-26-057751 |
| Aug 12, 2026 | 8-K | 0001628280-26-055962 |
| Jul 30, 2026 | 10-Q | 0001628280-26-050845 |
| Jul 30, 2026 | 8-K | 0001628280-26-050775 |
| Jul 29, 2026 | SCHEDULE 13G/A | 0002012383-26-002902 |
| Jul 20, 2026 | 144 | 0001628280-26-048913 |
| Jul 20, 2026 | 4 | 0001628280-26-048919 |
| Jun 18, 2026 | 4 | 0001628280-26-044290 |
| Jun 18, 2026 | 4 | 0001628280-26-044307 |
| Jun 18, 2026 | 4 | 0001628280-26-044346 |
| Jun 18, 2026 | 4 | 0001628280-26-044340 |
| Jun 18, 2026 | 4 | 0001628280-26-044325 |
| Jun 18, 2026 | 4 | 0001193125-26-275800 |
| Jun 17, 2026 | 8-K | 0001104659-26-075130 |
| Jun 17, 2026 | S-8 | 0001104659-26-075183 |
| Jun 1, 2026 | 4 | 0001628280-26-039653 |
| Jun 1, 2026 | 144 | 0001950047-26-005407 |
| May 22, 2026 | 4 | 0001628280-26-037830 |
| May 22, 2026 | 144 | 0001950047-26-004992 |